Ani Pharmaceuticals Inc (ANIP)
SG&A Expenses
$91.66M
Quarterly · Period ending: · USD
ANIP SG&A Expenses
Latest reported$91.66Mperiod ending
Latest reported$91.66Mperiod ending
ANIP Quarterly SG&A Expenses ($157.54K → $91.66M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ANIP sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 91,661,000 | |
| 73,655,000 | |
| 82,790,000 | |
| 76,656,000 | |
| 81,771,000 | |
| 76,528,000 | |
| 69,719,000 | |
| 79,075,000 | |
| 52,821,000 | |
| 48,021,000 | |
| 44,462,000 | |
| 42,007,000 | |
| 38,760,000 | |
| 36,468,000 | |
| 33,188,000 | |
| 30,081,000 | |
| 31,958,000 | |
| 28,817,000 | |
| 30,706,000 | |
| 17,181,000 | |
| 18,820,000 | |
| 17,587,000 | |
| 14,365,000 | |
| 15,725,000 | |
| 21,213,000 | |
| 13,683,000 | |
| 14,014,000 | |
| 14,357,000 | |
| 14,188,000 | |
| 13,284,000 | |
| 13,376,000 | |
| 11,769,000 | |
| 9,962,000 | |
| 8,956,000 | |
| 8,885,000 | |
| 8,022,000 | |
| 7,380,000 | |
| 7,293,000 | |
| 7,369,000 | |
| 6,928,000 | |
| 7,628,000 | |
| 5,904,000 | |
| 5,455,000 | |
| 5,399,000 | |
| 5,551,000 | |
| 4,751,000 | |
| 4,742,000 | |
| 4,057,000 | |
| 5,433,000 | |
| 3,703,000 | |
| 3,427,000 | |
| 3,561,216 | |
| 7,244,126 | |
| 1,949,114 | |
| 2,901,812 | |
| 1,546,864 | |
| 1,948,995 | |
| 1,831,852 | |
| 1,723,637 | |
| 1,675,268 | |
| 1,989,103 | |
| 1,593,557 | |
| 1,367,491 | |
| 1,534,417 | |
| 1,540,200 | |
| 1,767,002 | |
| 1,929,347 | |
| 1,506,056 | |
| 1,208,956 | |
| 1,029,202 | |
| 1,603,889 | |
| 1,438,816 | |
| 1,593,156 | |
| 1,325,493 | |
| 1,119,602 | |
| 1,027,194 | |
| 1,324,282 | |
| 992,387 | |
| 3,123,235 | |
| 210,552 | |
| 1,328,612 | |
| 2,363,019 | |
| 849,920 | |
| 704,966 | |
| 775,174 | |
| 720,495 | |
| 848,582 | |
| 488,298 | |
| 743,244 | |
| 1,000,011 | |
| 678,806 | |
| 481,073 | |
| 664,918 | |
| 502,293 | |
| 400,840 | |
| 413,804 | |
| 491,851 | |
| 459,129 | |
| 615,168 | |
| 720,461 |